Arthur G. Lipman, Pharm.D. - International Association for Hospice ...

Arthur G. Lipman
Page 14
Editorials (continued)
-continued-
Lipman, AG. J Pharm Care Pain Symptom Control. 1999;7
139. Science and anecdote: synergistic or antagonistic Number 1:1-1-2
140. A call for more evidence-based pharmacotherapy. Number 2:7-10.
141. Patient empowerment. Number 3:1-4.
142. Silent complicity in assisted death. Number 3:5-6
Lipman, AG. J Pharm Care Pain Symptom Control. 2000;8
143. Pain Standards Number 2:
144. NIH Consensus Statements, Number 2:
144. Drug-Diet Interactions in Palliative Care, Number 3:
Lipman AG. J Pharm Care Pain Symptom Control. 2001;9
145 Defining hospice and palliative care. (1):1-3.
146. Are pain clinicians generalists or specialists (2):1-2
147. Expanding palliative care in society. (2):5-6.
148. Expanding palliative care: Changes in society and in the journal. (3):5-6.
149. Expanding into the Journal of Pain & Palliative Care Pharmacotherapy. (4):1-3.
Lipman AG. J Pain Palliat Care Pharmacother. 2002:16
150. Clinical trial death from unregulated substance: Johns Hopkins recommends pharmacist and librarian collaboration.
(1): 1-4
151. Pain andpalliative care pharmacotherapy: A natural synergy. (1):5-7.
152. Evidence-based pain management and palliative care. (2):1-4.
153. Why we need outcomes research and pharmacoeconomics in pain management and palliative care. (3):1-4.
154. Complementary and alternative medicine. (4):1-4.
Lipman AG. J Pain Palliat Care Pharmacother. 2003:17
155. What have we learned from OxyContin (1):1-4.
156. Symptom control in advanced disease: Why all the fuss 92):1-4.
Lipman AG. J Pain Palliat Care Pharmacother. 2004:18
157. Advance Care Planning can Profoundly Influence Pain and Symptom Management. (1):1-4.
158. Does opiophobia exist among pain specialists (2):1-4
159. The Federal Ban on Ephedrine Dietary Supplements: An Important Event for Pain Practitioners and Patients. (3):1-5.
160. Pain Professionals’ Responsibility for Public Education. (4):1-4.
Lipman AG. J Pain Palliat Care Pharmacother. 2005:19
161. Does the DEA Truly Seek Balance in Pain Medicine (1):7-9 Arthur G. Lipman
162. Journal Innovations: Cover Art to Reflect Suffering and Relief from Pain and Related Symptoms, A Patient
Consultation Feature, and an Annual Award for the Best Paper in the Journal, (1):11-12.
163. Methadone: Effective Analgesia, Confusion and Risk (2):3-5.
164. Pharmacotherapists Need to Know Non-Drug Therapies (3):3-5.
165. Methadone: A Double Edged Sword (4):3-4.
166 The Complementary and Alternative Medicine Controversy Continues: The IOM Report (4):5-9.
167. New Features in the Journal: Hospice and Palliative Care and Expressions of Pain (4):10-11.
Lipman AG. J Pain Palliat Care Pharmacother. 2006:20
168. Lessons from our teachers. (1):3-4
169. Electronic access to information and the journal (2):3-4
170. A world in pain. (3):3-5
171. Coxibs and NSAIDs: a chronology of confusion (4): 7-9.
Continued